Aspirin, a salicylate drug, is an analgesic that contains acetylsalicylic acid. It is often used to relieve mild, continuous aches and pain at a specific region, such as muscle cramps, gastric distension or acute skin irritation. It can be used as an antipyretic to reduce fever or rheumatic fever, and also used as an anti-inflammatory medication for the treatment of rheumatoid arthritis, pericarditis, and Kawasaki disease. Aspirin has an antiplatelet effect by inhibiting the production of thromboxane, which under normal circumstances binds platelet molecules together to create a patch over damaged walls of blood vessels. Aspirin is also used long-term, at low doses, to help prevent heart attacks, strokes, and blood clot formation in people at high risk of developing blood clots. Aspirin may be effective at preventing certain types of cancer, particularly colorectal cancer. The adverse effects include gastrointestinal bleeding (caused by the drug concentrating too high in the walls of the stomach), tinnitus, Reye’s syndrome (characterized by acute encephalopathy, fatty liver, respiratory infection, chickenpox, or diarrhea), hives and swelling (symptoms resembling an allergic reaction caused by low salicylate intolerance but not a true allergy), angioedema (swelling of skin tissues), and cerebral microbleeds which often occur prior to ischemic stroke or intracerebral hemorrhage, Binswanger disease, and Alzheimer's disease.
In 1989, Mr. Yuan Lin discovered the Absolutely Constant Energy Source (ACES). He can utilize ACES to activate the genome responsible for inheritance, development and performance of body functions in the human body to control specific amino acid sequences and protein peptide chain formation processes, directing cell division, replication and new organelle formation. ACES was also applied to induce changes in the irreversible process of spontaneous biochemical reactions of carbohydrates, lipids, proteins, amino acids, enzymes, nucleic acids, vitamins, hormones, and trace elements. Mr. Yuan Lin thus had his body experience an unprecedented leap forward in human evolution, which has thoroughly changed the human biological form, structure, and habits inherited over billions of years, to become the first successfully-evolved New Human Line. The purpose of this experiment is to prove that Mr. Yuan Lin, the first successfully-evolved New Human Line, can utilize the Absolutely Constant Energy Source (ACES) to activate aspirin and change its concentration without any change in its molecular weight, structural formula, and conformation, at 25℃, 1.0 atm, and pH 7.0, in a confined and isolated space, and with no contact with catalysts, biologically active substances, chemical substances, and physical action forces, and also, by means of changes in the concentration, to control the biochemical reactions induced by aspirin so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects and avoid adverse medical reactions. Table 1. Comparison of the absorbance between two treatments at 248 nm From the above experimental results, we can see that there is significant difference (p=0.018) in the concentration between the control samples and the samples treated with ACES by Mr. Yuan Lin. It proved that Mr. Yuan Lin, the New Human Line, can utilize the Absolutely Constant Energy Source and the new biological engineering techniques to activate aspirin and change its concentration, and also, by means of changes in the concentration, to control the biochemical reactions induced by aspirin so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects, and avoid adverse medical reactions.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|